4/8
08:15 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
4/8
07:52 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
4/8
07:52 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
3/7
12:32 pm
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $20.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $20.00 price target on the stock.
3/7
12:32 pm
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $20.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $20.00 price target on the stock.
3/7
11:56 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
3/7
11:56 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/27
11:43 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
2/27
11:33 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
2/27
09:22 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
2/27
08:08 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
2/27
07:54 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
2/27
07:54 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
2/11
12:54 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/11
12:54 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/11
05:21 am
acad
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
Low
Report
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
2/11
05:21 am
acad
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
Low
Report
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank